Dr. Evan L. Kulbacki, MD
Pathology (Anatomic Pathology & Clinical Pathology Physician)
- Medicare participating
At a glance
- Medical school
- University of Utah School of Medicine (2008)
- Years since graduation
- 18
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 1,206
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Medical school: University of Utah School of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Anatomic Pathology & Clinical Pathology Physician primary
TN license 49647 -
Hematology (Pathology) Physician
TN license 49647
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Wellmont Holston Valley Medical Center Kingsport, TN
- Wellmont Bristol Regional Medical Center Bristol, TN
- Indian PAth Community Hospital Kingsport, TN
- Lonesome Pine Hospital Big Stone Gap, VA
- Lee County Community Hospital Pennington Gap, VA
Medical groups
- Highlands PAthology Consultants, P.c. (6 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,206
- Services billed
- 3,202
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 725 | 442 |
| Special stained specimen slides to examine tissue, each additional procedure | 406 | 108 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 357 | 357 |
| Special stained specimen slides to examine tissue, initial procedure | 194 | 169 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 127 | 26 |
| Blood smear interpretation by physician with written report | 120 | 109 |
| Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | 70 | 70 |
| Pap test, automated thin layer preparation; automated system and manual rescreening | 70 | 66 |
| Special stained specimen slides to examine tissue including interpretation and report | 66 | 46 |
| Cell examination of specimen, selective cellular enhancement technique | 64 | 57 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.